Portable visual-field testing devices show 86% sensitivity and 88% specificity for glaucoma diagnosisPortable devices show promise for diagnosing glaucoma more quickly

BMC ophthalmology Published August 7, 2026 Study authors: Alajlan Raghad Saleh, Almazrou Abdulrahman, Althubiti Lama, Alsenani Lama, Hazazi Bayan, Alsarhan Ya… PubMed ↗ DOI ↗ Editorial oversight: Dr. Lars van Dijk, PhD · Surgical, Procedural & Diagnostic

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway

Note that portable devices show high sensitivity (86%) and shorter test times but require further prospective validation.

This meta-analysis evaluated the diagnostic performance of various portable visual-field testing devices, including virtual-reality, tablet-based, web-based, and paper-based systems, compared to standard automated perimetry (SAP) for glaucoma. The study included a total population of 2,254 participants, consisting of 1,362 patients with glaucoma and 892 controls. The primary objective was to determine the diagnostic accuracy of these portable technologies in identifying glaucoma.

The analysis focused on several key metrics to establish diagnostic utility. The primary outcomes were sensitivity, specificity, and the diagnostic odds ratio (DOR). For the portable devices, the pooled sensitivity was reported at 86% (95% CI, 80-90). The pooled specificity was reported at 88% (95% CI, 80-93). These metrics resulted in a reported diagnostic odds ratio of 28.6 (95% CI, 14.3-57.2).

Secondary outcomes included measures of clinical efficiency and correlation with established standards. The study found that test duration was significantly shorter for portable perimetry overall compared to standard methods, with a reported effect size of -1.60 (SMD) and a 95% CI of -2.63 to -0.57. Furthermore, the analysis showed a strong correlation between the global index of portable devices and established metrics, with an r value of 0.82 (95% CI, 0.75-0.88).

Safety and tolerability data were not reported in the included studies for this meta-analysis. Consequently, specific rates of adverse events or discontinuations are unknown from this dataset. The findings focus strictly on the diagnostic accuracy and time efficiency of the hardware interfaces.

These results provide a baseline for comparing portable technologies against traditional SAP. While current evidence suggests that portable devices offer high sensitivity and specificity, they must be viewed through the lens of study design limitations. Many included studies utilized case-control designs, which can lead to optimistic pooled accuracy estimates compared to real-world prevalence.

Methodological limitations include significant heterogeneity in study designs, varying diagnostic thresholds across different platforms, and inconsistent performance metrics across the various portable modalities (virtual-reality vs. paper-based). These inconsistencies may affect the generalizability of the pooled results across all types of portable devices.

Clinically, these results indicate that portable devices show promising diagnostic performance and reduced testing time compared to standard automated perimetry. However, because of the potential for optimistic estimates from case-control designs and the lack of prospective data, these tools should not currently be used as stand-alone diagnostic tools. They may serve as useful adjuncts in specific clinical settings where speed or portability is required.

Several questions remain regarding the long-term reliability of different portable modalities. Specifically, it is unclear if all types of portable devices (e.g., paper-based vs. virtual-reality) perform with equal accuracy. Further prospective, population-based studies are necessary to validate these tools as reliable components of a glaucoma management workflow.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap in the diagnostic toolkit for glaucoma by evaluating portable technologies. While previous reports have explored different diagnostic and treatment modalities, such as dynamic gratings for neuro-ophthalmic conditions or surgical interventions for refractive errors, this meta-analysis specifically quantifies the accuracy of mobile perimetry tools compared to standard automated perimetry.

Glaucoma is a serious eye condition that can lead to permanent vision loss if it is not caught early. For many people living with this condition, the standard way of testing the eyes involves long and sometimes tedious procedures. This research looked into whether portable devices, such as those using tablets or virtual reality, could provide an easier and faster way to check for glaucoma while still being accurate enough to help doctors make decisions.

the researchers conducted a meta-analysis, which is a study that combines the results of many different trials to find a broad trend. They looked at data from 2,254 people, including 1,362 people with glaucoma and 892 people without it. These individuals were tested using various portable devices, such as web-based or paper-based systems, and compared those results against the standard automated perimetry (SAP) currently used in many clinics.

The findings showed that these portable tools performed well. The tests had a sensitivity of 86 percent and a specificity of 88 percent. In plain terms, this means the portable devices were quite good at correctly identifying people with glaucoma and correctly identifying those without it. One of the most significant findings was that these portable tests took much less time to complete than the standard tests. The study also found a strong correlation between the results of the portable tools and the traditional methods used by eye doctors.

While these results are encouraging, there are important reasons to be cautious before changing how eye care is delivered. Because many of the individual studies included in this analysis were case-control designs, the overall accuracy numbers might look better than they would in a real-world setting. Additionally, different types of portable devices used different settings and metrics, making it hard to compare every device exactly. There was no reported information regarding safety concerns or side effects for patients using these tools.

For patients right now, this means that while portable technology shows great potential to make eye exams faster and more convenient, it is not yet ready to replace standard tests entirely. These devices are currently seen as promising tools rather than standalone diagnostic machines. More large-scale studies involving diverse groups of people in everyday clinical settings are needed before these portable options can be used as the primary way to diagnose glaucoma on their own.

What this means for you:

Portable vision tests show promise for faster diagnosis, but more research is needed before they replace standard tests.

Study Details

Study typeMeta analysis

Sample sizen = 2,254

EvidenceLevel 1

PublishedAug 2026

PMID42563154

View Original Abstract ↓

BACKGROUND: Portable visual-field testing devices have emerged as accessible approaches for detecting and monitoring manifest glaucomatous visual-field loss, particularly where standard automated perimetry is difficult to access. Their diagnostic accuracy and clinical reliability, however, remain uncertain due to heterogeneous study designs, variable thresholds, and inconsistent performance metrics. This systematic review and meta-analysis aimed to evaluate the diagnostic accuracy, test duration, and correlation of all portable VF devices compared with SAP, across multiple device categories and glaucoma severities. METHODS: A comprehensive search of PubMed, Scopus, Web of Science, Cochrane Central, ClinicalTrials.gov, WHO ICTRP, and Google Scholar was conducted from inception through December 2025, without language restrictions. Eligible studies included diagnostic-accuracy or cohort designs comparing portable VF devices, including virtual-reality, tablet-based, web-based, or paper-based against SAP as the reference standard. Two reviewers independently extracted data and assessed quality using QUADAS-2. Pooled sensitivity, specificity, and diagnostic odds ratios (DOR) were calculated using bivariate random-effects models, with heterogeneity and publication bias evaluated via I², τ², and Deeks' funnel asymmetry tests. Secondary outcomes included test duration and correlation coefficients for mean deviation (MD), pattern standard deviation (PSD), and visual field index (VFI). RESULTS: From 639 screened records, 21 studies involving 2,254 participants (1,362 glaucoma, 892 controls) were included. Pooled sensitivity was 86% (95% CI, 80-90) and pooled specificity 88% (95% CI, 80-93), with an overall DOR of 28.6 (95% CI, 14.3-57.2). Substantial heterogeneity was observed across studies and device categories. Virtual-reality/head-mounted devices showed the highest diagnostic performance, whereas tablet-based devices demonstrated the lowest pooled specificity; however, sensitivity did not differ significantly between device categories, and specificity differences were not statistically significant. Test durations were significantly shorter for portable perimetry overall (SMD - 1.60; 95% CI, - 2.63 to - 0.57), with the largest reductions for tablet-based and paper-based devices, whereas VR/head-mounted systems showed no significant difference. Global index correlations were strong (r = 0.82; 95% CI, 0.75-0.88). CONCLUSIONS: In included validation studies, portable visual-field devices showed promising diagnostic performance relative to SAP for detecting manifest glaucomatous visual-field loss in validation-study settings, and most devices reduced testing time. However, because many studies used case-control designs, pooled accuracy estimates may be optimistic. Prospective, population-based studies in unselected cohorts are needed before these technologies are used as stand-alone diagnostic tools. These technologies represent potentially scalable tools requiring further validation for improving global glaucoma detection and ongoing disease management.

Portable visual-field testing devices show 86% sensitivity and 88% specificity for glaucoma diagnosisPortable devices show promise for diagnosing glaucoma more quickly

How this fits prior evidence

Study Details

Systematic review of extensive macular atrophy with pseudodrusen reports visual acuity decline and atrophy progression

Eye disease linked to vision loss and thicker eye layers in study

Clinical research that matters. Delivered to your inbox.

Portable visual-field testing devices show 86% sensitivity and 88% specificity for glaucoma diagnosisPortable devices show promise for diagnosing glaucoma more quickly

How this fits prior evidence

More on Glaucoma

Study Details

Systematic review of extensive macular atrophy with pseudodrusen reports visual acuity decline and atrophy progression

Eye disease linked to vision loss and thicker eye layers in study

Clinical research that matters. Delivered to your inbox.

Related in Ophthalmology

From Other Specialties